These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 9650913)
1. Chromosome 16q24 deletion and decreased E-cadherin expression: possible association with metastatic potential in prostate cancer. Pan Y; Matsuyama H; Wang N; Yoshihiro S; Häggarth L; Li C; Tribukait B; Ekman P; Bergerheim US Prostate; 1998 Jun; 36(1):31-8. PubMed ID: 9650913 [TBL] [Abstract][Full Text] [Related]
2. Loss of heterozygosity at chromosome 16q in prostate adenocarcinoma: identification of three independent regions. Latil A; Cussenot O; Fournier G; Driouch K; Lidereau R Cancer Res; 1997 Mar; 57(6):1058-62. PubMed ID: 9067271 [TBL] [Abstract][Full Text] [Related]
3. Allelic imbalance mapping of chromosome 16 shows two regions of common deletion in prostate adenocarcinoma. Godfrey TE; Cher ML; Chhabra V; Jensen RH Cancer Genet Cytogenet; 1997 Oct; 98(1):36-42. PubMed ID: 9309116 [TBL] [Abstract][Full Text] [Related]
4. Three distinct commonly deleted regions of chromosome arm 16q in human primary and metastatic prostate cancers. Suzuki H; Komiya A; Emi M; Kuramochi H; Shiraishi T; Yatani R; Shimazaki J Genes Chromosomes Cancer; 1996 Dec; 17(4):225-33. PubMed ID: 8946204 [TBL] [Abstract][Full Text] [Related]
5. Mapping of regions of physical deletion on chromosome 16q in prostate cancer cells by fluorescence in situ hybridization (FISH). Cher ML; Ito T; Weidner N; Carroll PR; Jensen RH J Urol; 1995 Jan; 153(1):249-54. PubMed ID: 7966782 [TBL] [Abstract][Full Text] [Related]
6. Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. Umbas R; Schalken JA; Aalders TW; Carter BS; Karthaus HF; Schaafsma HE; Debruyne FM; Isaacs WB Cancer Res; 1992 Sep; 52(18):5104-9. PubMed ID: 1516067 [TBL] [Abstract][Full Text] [Related]
7. Clinical significance of chromosome 8p, 10q, and 16q deletions in prostate cancer. Matsuyama H; Pan Y; Yoshihiro S; Kudren D; Naito K; Bergerheim US; Ekman P Prostate; 2003 Feb; 54(2):103-11. PubMed ID: 12497583 [TBL] [Abstract][Full Text] [Related]
9. Interphase cytogenetics of prostatic adenocarcinoma and precursor lesions: analysis of 25 radical prostatectomies and 17 adjacent prostatic intraepithelial neoplasias. Alers JC; Krijtenburg PJ; Vissers KJ; Bosman FT; van der Kwast TH; van Dekken H Genes Chromosomes Cancer; 1995 Apr; 12(4):241-50. PubMed ID: 7539277 [TBL] [Abstract][Full Text] [Related]
10. Fluorescence in situ hybridization to assess transitional changes of aneuploidy for chromosomes 7, 8, 10, 12, 16, X and Y in metastatic prostate cancer following anti-androgen therapy. Kasahara K; Taguchi T; Yamasaki I; Karashima T; Kamada M; Yuri K; Shuin T Int J Oncol; 2001 Sep; 19(3):543-9. PubMed ID: 11494034 [TBL] [Abstract][Full Text] [Related]
11. Chromosome 16 in primary prostate cancer: a microsatellite analysis. Osman I; Scher H; Dalbagni G; Reuter V; Zhang ZF; Cordon-Cardo C Int J Cancer; 1997 May; 71(4):580-4. PubMed ID: 9178811 [TBL] [Abstract][Full Text] [Related]
12. Distinct deleted regions on chromosome segment 16q23-24 associated with metastases in prostate cancer. Li C; Berx G; Larsson C; Auer G; Aspenblad U; Pan Y; Sundelin B; Ekman P; Nordenskjöld M; van Roy F; Bergerheim US Genes Chromosomes Cancer; 1999 Mar; 24(3):175-82. PubMed ID: 10451696 [TBL] [Abstract][Full Text] [Related]
13. Location of KAI1 on the short arm of human chromosome 11 and frequency of allelic loss in advanced human prostate cancer. Kawana Y; Komiya A; Ueda T; Nihei N; Kuramochi H; Suzuki H; Yatani R; Imai T; Dong JT; Imai T; Yoshie O; Barrett JC; Isaacs JT; Shimazaki J; Ito H; Ichikawa T Prostate; 1997 Aug; 32(3):205-13. PubMed ID: 9254900 [TBL] [Abstract][Full Text] [Related]
14. Gain and loss of chromosomes 1, 7, 8, 10, 18, and Y in 46 prostate cancers. König JJ; Teubel W; Romijn JC; Schröder FH; Hagemeijer A Hum Pathol; 1996 Jul; 27(7):720-7. PubMed ID: 8698318 [TBL] [Abstract][Full Text] [Related]
15. Loss of heterozygosity at 16q24.1-q24.2 is significantly associated with metastatic and aggressive behavior of prostate cancer. Elo JP; Härkönen P; Kyllönen AP; Lukkarinen O; Poutanen M; Vihko R; Vihko P Cancer Res; 1997 Aug; 57(16):3356-9. PubMed ID: 9269995 [TBL] [Abstract][Full Text] [Related]
16. Allele loss on chromosome 16q24.2-qter occurs frequently in breast cancers irrespectively of differences in phenotype and extent of spread. Tsuda H; Callen DF; Fukutomi T; Nakamura Y; Hirohashi S Cancer Res; 1994 Jan; 54(2):513-7. PubMed ID: 8275489 [TBL] [Abstract][Full Text] [Related]
17. Interphase cytogenetics of prostatic tumor progression: specific chromosomal abnormalities are involved in metastasis to the bone. Alers JC; Krijtenburg PJ; Rosenberg C; Hop WC; Verkerk AM; Schröder FH; van der Kwast TH; Bosman FT; van Dekken H Lab Invest; 1997 Nov; 77(5):437-48. PubMed ID: 9389787 [TBL] [Abstract][Full Text] [Related]
18. Loss and gain of chromosomes 1, 18, and Y in prostate cancer. König JJ; Teubel W; van Dongen JW; Romijn JC; Hagemeijer A; Schröder FH Prostate; 1994 Dec; 25(6):281-91. PubMed ID: 7527913 [TBL] [Abstract][Full Text] [Related]
19. S-phase fraction related to prognosis in localised prostate cancer. No specific significance of chromosome 7 gain or deletion of 7q31.1. Aström L; Weimarck A; Aldenborg F; Delle U; Hanson C; Verbiene I; Danielsson A; Hammarsten J; Köpf I Int J Cancer; 1998 Dec; 79(6):553-9. PubMed ID: 9842961 [TBL] [Abstract][Full Text] [Related]
20. Allelic loss of chromosomes 16q and 10q in human prostate cancer. Carter BS; Ewing CM; Ward WS; Treiger BF; Aalders TW; Schalken JA; Epstein JI; Isaacs WB Proc Natl Acad Sci U S A; 1990 Nov; 87(22):8751-5. PubMed ID: 1978938 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]